Company Filing History:
1 out of 4,455 
1 out of 55 
1 out of 1 Years Active: 2005
Title: The Innovations of Robert Trygve Good
Introduction
Robert Trygve Good is an accomplished inventor based in Romsey, Australia. He has made significant contributions to the field of therapeutic compositions, particularly in the treatment of infections caused by Lawsonia spp. His work has implications for both animal and bird health, showcasing his dedication to improving veterinary medicine.
Latest Patents
Robert Trygve Good holds a patent for "Therapeutic compositions for treating infection by Lawsonia spp." This invention relates to therapeutic compositions aimed at treating and preventing intestinal disease conditions in animals and birds. The patent details a novel gene that encodes an immunogenic polypeptide, which is useful as an antigen in vaccine preparations. This innovation is particularly aimed at conferring humoral immunity against related pathogens in animal hosts. The polypeptide is selected from a specific group, including flhB, fliR, ntrC, glnH, motA, motB, tlyC, ytfM, and ytfN polypeptides, or their homologues, analogues, or derivatives. Additionally, the invention encompasses methods for treatment and diagnostic agents for detecting related microorganisms.
Career Highlights
Throughout his career, Robert has worked with notable organizations, including Pfizer Corporation and Agriculture Victoria Services Pty Limited. His experience in these companies has allowed him to develop and refine his innovative ideas, contributing to advancements in therapeutic solutions for animal health.
Collaborations
Robert has collaborated with esteemed colleagues such as Everett Lee Rosey and Kendall Wayne King. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field of veterinary therapeutics.
Conclusion
Robert Trygve Good's contributions to the field of veterinary medicine through his innovative patent demonstrate his commitment to improving animal health. His work not only addresses critical health issues but also paves the way for future advancements in therapeutic compositions.